This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Yoshiki Hayashi: Innovator in Antibody Stabilization
Introduction
Yoshiki Hayashi is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of stabilized antibody preparations. His work is crucial for advancing therapeutic applications in medicine.
Latest Patents
Yoshiki Hayashi holds a patent for "Stabilized anti-interleukin-6 antibody-containing preparations." This invention provides stabilized preparations containing an antibody in a glycine buffer and/or a histidine buffer. It also outlines processes for preparing a protein-containing stabilized preparation, which involves adjusting the pH with a basic amino acid or a basic amino acid derivative or a salt thereof. This innovation is vital for enhancing the efficacy and stability of antibody-based treatments.
Career Highlights
Hayashi is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on developing advanced therapeutic solutions that address critical health challenges. With 1 patent to his name, he has established himself as a key figure in the field of antibody research.
Collaborations
Yoshiki Hayashi has collaborated with notable colleagues, including Masaya Kakuta and Tadao Yamazaki. These partnerships have fostered innovation and contributed to the success of their projects in the biotechnology sector.
Conclusion
Yoshiki Hayashi's contributions to the field of antibody stabilization are noteworthy. His innovative patent and collaboration with esteemed colleagues highlight his commitment to advancing medical science. His work continues to impact the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
